Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113735778B enables high-purity imidazole intermediates through simplified process with cost reduction in pharmaceutical manufacturing.
Patent CN103467351B enables water-based asymmetric Aldol reactions with >99% ee, reducing solvent waste and supply chain complexity for pharmaceutical intermediates.
Patent CN113735778B enables high-purity trifluoromethyl imidazoles through scalable silver-promoted cycloaddition, reducing costs and lead times for pharmaceutical intermediates.
Patent CN114195726B enables scalable triazolyl arylamine synthesis with simplified process, reducing lead time and cost in pharmaceutical manufacturing.
Patent CN109761984B enables high-purity API intermediates through asymmetric hydrogen transfer with enhanced supply chain reliability and reduced manufacturing costs.
Patent CN112480015B enables high-purity quinazolinone synthesis with cost reduction in pharmaceutical manufacturing through efficient one-pot methodology.
Patent CN102382051A enables high-purity isoquinolinone intermediates with streamlined manufacturing, reducing lead time and cost for pharmaceutical supply chains.
This nickel-catalyzed synthesis method enables high-purity API intermediates with reduced manufacturing costs and faster commercial scale-up for pharmaceutical supply chains.
Advanced palladium-catalyzed synthesis enables high-purity API intermediates with streamlined manufacturing processes and substantial cost reduction for pharmaceutical companies.
Patent CN113735778B enables efficient production of high-purity API intermediates with simplified process, reducing lead time and manufacturing costs for pharmaceutical supply chains.
Patent CN115260080B enables high-purity indole-3-carboxamide production through palladium-catalyzed carbonylation, reducing lead times and ensuring scalable supply for pharmaceutical applications.
Patent CN117164534A enables high-purity API intermediates through simplified catalytic process, reducing lead time and manufacturing costs for pharmaceutical supply chains.
Patent CN119823129A enables efficient one-step synthesis of complex quinolinone intermediates with high substrate compatibility and simplified supply chain operations.
Patent CN116813516B enables safer carbonylation using dual-source reagents, enhancing supply chain resilience and reducing costs for high-purity pharmaceutical intermediates.
Patent CN111592507A enables rapid high-yield furan synthesis with mild conditions reducing manufacturing costs and lead times for pharmaceutical intermediates.
Patent CN114524701B enables high-purity N-N axis chiral pyrrole intermediates with mild reaction conditions, enhancing supply chain reliability and reducing API manufacturing costs.
Sulfur-promoted method eliminates hazardous reagents enabling cost-effective production of high-purity triazole intermediates with reliable supply chain.
Metal-free synthesis of 5-trifluoromethyl triazole compounds enables scalable production with high purity and reduced manufacturing costs for pharmaceutical applications.
Patent CN116813544B enables green synthesis of high-purity quinoline intermediates without catalysts or additives, reducing manufacturing costs and lead times for pharmaceutical supply chains.
Innovative palladium-catalyzed method eliminates toxic CO gas enabling high-purity production with reduced lead time and scalable manufacturing advantages.